NeuroMetrix

Neurometrix receives FDA OK for OTC use of its wearable chronic pain gadget

Massachusetts-based Neurometrix just received 510(k) clearance from the Food and Drug Administration for over-the-counter use of its wearable gadget that treats chronic pain. The lightweight device, which is still under development and projected for commercial launch next year, emits electric jolts to the wearer. It is modeled after Sensus, the company’s device that treats pain associated with […]

Devices & Diagnostics

Device design: Wearable diabetic neuropathy pain management system strives for simplicity

When Massachusetts-based Neurometrix (NURO) created a wearable device for pain management for patients suffering from diabetic peripheral neuropathy (DPN), founder and CEO Shai Gozani knew usability was key. More than a quarter of diabetic patients must cope with DPN, a burning, stabbing, acute pain, usually in the legs and feet, Gozani said. The Sensus, NURO’s nerve-stimulator […]

Devices & Diagnostics

Diabetes blood test boosted by NeuroMetrix, Nipro pact

Nipro Corp. (TYO:8086) and NeuroMetrix Inc. (NSDQ:NURO) announced a collaboration to market NeuroMetrix’s NC-stat diagnostic nerve testing device. The NC-stat test is a quantitative point-of-care test that evaluates systemic neuropathies like diabetic peripheral neuropathy, a common disease affecting more than half of diabetics which may lead to foot ulcers and limb amputation. This may be […]